Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1

抄録

<jats:sec><jats:title>Objective</jats:title><jats:p>Type 2 diabetes is a risk factor for dementia. We investigated whether serum levels of soluble triggering receptor expressed on myeloid cell 2 (sTREM2), a soluble form of the cell surface receptor TREM2, were predictive of cognitive impairment in type 2 diabetes without obesity.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A total of 166 Japanese patients with type 2 diabetes without obesity were followed-up for 2 years. We measured clinical parameters, assessed cognitive function using the mini-mental state examination (MMSE), quantified and divided serum sTREM2 levels into quartiles, and examined the longitudinal associations.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>During the follow-up, HbA<jats:sub>1c</jats:sub> levels were elevated in 98 patients and decreased in 68 patients. In the HbA<jats:sub>1c</jats:sub>-elevated group, higher sTREM2 levels at baseline showed a significant association with a greater tendency for reduction in MMSE scores (<jats:italic>P</jats:italic> for trend = 0.015), whereas they were not significantly associated with other examined parameters. In the HbA<jats:sub>1c</jats:sub>-decreased group, there was no significant association between sTREM2 levels at baseline and changes in MMSE scores, but higher sTREM2 levels at baseline were significantly associated with a greater tendency for reduction in waist circumference (<jats:italic>P</jats:italic> for trend = 0.027), homeostasis model assessment of insulin resistance (<jats:italic>P</jats:italic> for trend = 0.039), and sTREM2 levels (<jats:italic>P</jats:italic> for trend = 0.023).</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Glycemic control is suggested to be important in preventing cognitive impairment in patients with type 2 diabetes without obesity. Higher serum sTREM2 levels would be a predictive marker for cognitive impairment in inadequately controlled type 2 diabetes without obesity.</jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (36)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ